Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Leukemia

Free Subscription 23.02.2026 5 Ann Hematol 2 Blood 1 Bone Marrow Transplant 9 Br J Haematol 1 Eur J Haematol 2 Exp Hematol 1 Genes Chromosomes Cancer 4 Int J Hematol 2 Leuk Lymphoma 3 Leukemia 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Hematol

1. SHIMOMURA Y, Komukai S, Kitamura T, Sobue T, et al
   The optimal conditioning intensity of stem cell transplantation for acute myeloid leukemia in complete remission.
   Ann Hematol. 2026;105:124.
   PubMed        
   
   
2. MAZZARELLA R, Cicconi L, Perrone S, Divona MD, et al
   Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia.
   Ann Hematol. 2026;105:121.
   PubMed         Abstract available
   
   
3. NG JY, Gullapalli V, Othman J, Talaulikar D, et al
   Re-treatment of relapse in elderly AML with time-limited venetoclax-based regimen: a case report and literature review.
   Ann Hematol. 2026;105:120.
   PubMed         Abstract available
   
   
4. AKIMOTO M, Tachibana T, Tanaka M, Izumi A, et al
   Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia.
   Ann Hematol. 2026;105:118.
   PubMed         Abstract available
   
   
5. JI Q, Jiang X, Li X, Cao C, et al
   Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia.
   Ann Hematol. 2026;105:119.
   PubMed         Abstract available
   
   

   
   Blood

6. ATTARDI E, Gray N, Lewis S, Boals M, et al
   Utility of peripheral blood testing for detection and surveillance of clonal hematopoiesis in predisposed individuals.
   Blood. 2026;147:897-901.
   PubMed         Abstract available
   
   
7. LING T, O'Brien C, St-Germain JR, Rondeau V, et al
   Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.
   Blood. 2026;147:863-876.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

8. VYDRA J, Ferhat AT, Kroger N, Gedde-Dahl T, et al
   Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrosp
   Bone Marrow Transplant. 2026;61:206-210.
   PubMed         Abstract available
   
   

   
   Br J Haematol

9. KRISTENSEN DT, Simonsen MR, Roug AS, Marcher CW, et al
   Outcomes among non-Western immigrant patients and Danish-born patients with acute myeloid Leukaemia: A Danish population-based cohort study.
   Br J Haematol. 2026;208:564-569.
   PubMed         Abstract available
   
   
10. LIST J, Sollier E, Brown-Burke F, Kelly K, et al
    Genocopy of EVI1-AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking.
    Br J Haematol. 2026;208:498-502.
    PubMed         Abstract available
    
    
11. LEE BJ, Griffin SP, Doh J, Quach A, et al
    Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia.
    Br J Haematol. 2026;208:570-578.
    PubMed         Abstract available
    
    
12. YAO CY, Hsu CL, Yang YT, Tien FM, et al
    Genomic and transcriptomic characterization of acute myeloid leukaemia with IL3RA overexpression: Prognostic and therapeutic implications revisited.
    Br J Haematol. 2026;208:503-513.
    PubMed         Abstract available
    
    
13. KYNNING MK, Westerberg E, Forsell L, Creignou M, et al
    Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based study.
    Br J Haematol. 2026;208:514-523.
    PubMed         Abstract available
    
    
14. WANG LY, Gao HT, Fu Q, Jiang Q, et al
    Decoding the molecular drivers of TP53-mutant acute myeloid leukaemia: Clinical implications and prognostic insights.
    Br J Haematol. 2026;208:579-588.
    PubMed         Abstract available
    
    
15. PETERS DT, Nicolet D, Madanat YF, Gonzalez-Lugo J, et al
    Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortium.
    Br J Haematol. 2026;208:589-598.
    PubMed         Abstract available
    
    
16. JIN H, Guo Z, Zhu L, Huang F, et al
    Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis.
    Br J Haematol. 2026;208:524-533.
    PubMed         Abstract available
    
    
17. YEUNG DT, Grigg AP, Reynolds J, Branford S, et al
    The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-alpha2b in newly diagnosed chronic phase chronic myeloid leukaemia.
    Br J Haematol. 2026;208:599-607.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

18. TIDSWELL R, Owen C, Shafey M, Perry S, et al
    Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Eur J Haematol. 2026 Feb 16. doi: 10.1111/ejh.70137.
    PubMed         Abstract available
    
    

    
    Exp Hematol

19. UEDA K, Sato Y, Minakawa K, Miura S, et al
    Loss of Ezh2 precipitates lethal disease progression in a mouse model of Calr-mutated myeloproliferative neoplasms.
    Exp Hematol. 2026;155:105350.
    PubMed         Abstract available
    
    
20. NISHIKII H, Kikuchi R, Kimura T, Saito M, et al
    Tumor necrosis factor from leukemic environment stimulates hematopoietic stem/progenitor cells toward megakaryocyte/myeloid lineage bias.
    Exp Hematol. 2026;155:105332.
    PubMed         Abstract available
    
    

    
    Genes Chromosomes Cancer

21. JALUD FB, Ibnat T, Kew K, Brown LM, et al
    IRF2BP2::JAK2 Defines a Novel Kinase-Activating Fusion in Pediatric T-Cell Acute Lymphoblastic Leukemia.
    Genes Chromosomes Cancer. 2026;65:e70112.
    PubMed         Abstract available
    
    

    
    Int J Hematol

22. KOJIMA K, Tsuge N, Yoshida S, Umebara D, et al
    Myelodysplastic neoplasms with unbalanced whole-arm translocation der(5;19)(p10;q10): association with double-hit TP53 mutations.
    Int J Hematol. 2026;123:189-195.
    PubMed         Abstract available
    
    
23. IZUTSU K, Watanabe M, Toubai T, Tsukamoto T, et al
    Efficacy and safety of fixed-duration venetoclax plus obinutuzumab in untreated Japanese CLL and SLL: a phase 2 study.
    Int J Hematol. 2026;123:225-232.
    PubMed         Abstract available
    
    
24. SHEN Y, Zhang P, He A, Wang J, et al
    Azacitidine monotherapy versus combination regimens as post-HSCT maintenance therapy in high-risk myeloid malignancies: a retrospective cohort study.
    Int J Hematol. 2026;123:270-278.
    PubMed         Abstract available
    
    
25. ISHIDA H, Suenobu S, Imamura T, Shiwaku T, et al
    Outcomes of children with T-cell acute lymphoblastic leukemia treated with the JACLS T-02 protocol.
    Int J Hematol. 2026 Feb 17. doi: 10.1007/s12185-026-04178.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

26. DYMOCK SCC, Oommen J, Malinge S, Cheung LC, et al
    Menin inhibitors display differential in vitro sensitivity in KMT2A-rearranged infant acute lymphoblastic leukemia.
    Leuk Lymphoma. 2026 Feb 19:1-5. doi: 10.1080/10428194.2026.2631099.
    PubMed        
    
    
27. HUGHES EE, Baron J, Wang ES, Yu H, et al
    Mini-HyperCVD in secondary acute lymphoblastic leukemia following multiple myeloma treatment from lenalidomide: a case series.
    Leuk Lymphoma. 2026 Feb 17:1-4. doi: 10.1080/10428194.2026.2631107.
    PubMed        
    
    

    
    Leukemia

28. LAUSEKER M, Sacha T, Klamova H, Yakoleva J, et al
    Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.
    Leukemia. 2026 Feb 19. doi: 10.1038/s41375-026-02875.
    PubMed         Abstract available
    
    
29. WANG C, Ge S, Gao J, Yang R, et al
    The fragile equilibrium of cancer latency: lessons from spontaneous remission in congenital leukemia.
    Leukemia. 2026 Feb 17. doi: 10.1038/s41375-026-02888.
    PubMed        
    
    
30. CHAKRABORTY S, Morganti C, Zaldana K, Rivera Pena B, et al
    A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.
    Leukemia. 2026 Feb 17. doi: 10.1038/s41375-026-02883.
    PubMed         Abstract available
    
    

    
    PLoS One

31. ZOLFAGHARI M, Saniee Abadeh M, Sajedi H
    Design and development of a convolutional neural network based on human cognitive attention mechanism for automatic classification of leukemia.
    PLoS One. 2026;21:e0336770.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum